Elias Kouchakji
Chief Tech/Sci/R&D Officer chez FIBROGEN, INC.
Profil
Actuellement, Elias Kouchakji occupe le poste de vice-président senior du développement clinique et de la sécurité des médicaments chez FibroGen, Inc. Dans le cadre de sa carrière antérieure, il a occupé les postes de directeur exécutif de la médecine et de la sécurité chez Amgen, Inc. et de chef mondial de la pharmacovigilance et de la gestion des risques chez Perrigo Co. Plc et Global Head-Pharmacovigilance & Risk Management chez Elan Pharmaceuticals LLC (une filiale de Perrigo Co. Plc), Head-US Safety chez Hoffmann-La Roche, Inc. et Director-Drug Safety & Pharmacovigilance chez EMD Serono, Inc. Elias Kouchakji a obtenu un doctorat de l'université de Damas.
Postes actifs de Elias Kouchakji
| Sociétés | Poste | Début |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Anciens postes connus de Elias Kouchakji
| Sociétés | Poste | Fin |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| PERRIGO COMPANY PLC | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Elias Kouchakji
| Damascus University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| PERRIGO COMPANY PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
